Rep. Ro Khanna, a Democrat from California, has announced his intention to introduce legislation that would codify President Donald Trump’s executive order aimed at lowering prescription drug prices. The initiative is part of a broader effort to address the high cost of medications in the United States, a longstanding issue that has drawn attention from both political parties.
Khanna’s proposal comes amid ongoing discussions about the role of government in regulating pharmaceutical prices. While the Trump administration’s executive order sought to provide relief by allowing Medicare to negotiate drug prices, Khanna’s legislation would seek to make these measures permanent, ensuring continued oversight and potential cost reductions for Medicare beneficiaries.
The move has been met with mixed reactions from industry stakeholders and healthcare professionals. Supporters argue that the legislation could provide long-term stability and affordability for patients, while critics express concerns about the potential impact on pharmaceutical innovation and investment.